Julie B. Feder
2017 - Verastem
In 2017, Julie B. Feder earned a total compensation of $1.1M as Chief Financial Officer at Verastem.
Compensation breakdown
| Non-Equity Incentive Plan | $60,000 |
|---|---|
| Option Awards | $878,024 |
| Salary | $150,385 |
| Other | $6,708 |
| Total | $1,095,117 |
Feder received $878K in option awards, accounting for 80% of the total pay in 2017.
Feder also received $60K in non-equity incentive plan, $150.4K in salary and $6.7K in other compensation.
Rankings
In 2017, Julie B. Feder's compensation ranked 8,558th out of 14,666 executives tracked by ExecPay. In other words, Feder earned more than 41.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,558 out of 14,666 | 42nd |
Division Manufacturing | 3,246 out of 5,772 | 44th |
Major group Chemicals And Allied Products | 1,083 out of 2,075 | 48th |
Industry group Drugs | 857 out of 1,731 | 51st |
Industry Pharmaceutical Preparations | 668 out of 1,333 | 50th |
Source: SEC filing on April 10, 2018.
Feder's colleagues
We found two more compensation records of executives who worked with Julie B. Feder at Verastem in 2017.